Physician profile
Paul Dyrud
NPI 1811494230
$4,382.06
in general payments reported to CMS, 2019-2025
7 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $130 · 2023: $791 · 2024: $3,273 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $2,000 · Food and Beverage: $1,322 · Education: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $2,000.00 |
| Food and Beverage | $1,321.82 |
| Education | $929.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,051.27 | 2023-2024 | Endurant Iis |
| W. L. Gore & Associates, INC. | $712.77 | 2024-2025 | Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis |
| Advanced Oxygen Therapy INC. | $149.94 | 2025 | Topical Oxygen Chamber For Extremities |
| Penumbra, INC. | $141.31 | 2024 | Penumbra System |
| Stryker Corporation | $130.25 | 2022 | |
| Atricure, INC. | $107.83 | 2023 | |
| Surmodics, INC. | $88.69 | 2024-2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy, Pounce Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Dyrud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.